"Designing Growth Strategies is in our DNA"

Point of Care (POC) Diagnostics Market Size, Share and Industry Analysis By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Regional Forecast 2019-2026

Region : Global | Format: PDF | Report ID: FBI101072



Play Audio Listen to Audio Version
COVID-19 Cover

We are in process of revamping Point-of-Care Diagnostics Market with respect to COVID-19 Impact.

Inquire before buying

Existing market players operating in the global point-of-care diagnostics market are focusing on constant innovation and up-gradation of their product portfolio with new and efficient product offerings for better and accurate diagnostics outcomes for the patients. One of the critical reasons for the growth of the global point of care testing market is the increasing demand for efficient diagnostics at the place of care such as intensive units for the patients, driven by the increasing number of medical procedures and the increasing number of hospitalizations. Rise in awareness regarding point-of-care diagnostics in both developing and developed nations, and the emergence of new products with advanced technologies and greater accuracies is propelling the growth of the global point of care diagnostics market.

Request a sample to learn more about this report.

This, coupled with, increasing investments by major players in research and development for new POC testing, are also boosting the growth of the market globally. The increased demand in the POC diagnostics market is also primarily driven by increased demand for diagnostics results in shorter periods than the traditional waiting times of days. Some of the other factors which are also contributing to the growth of the market are the increase in the medical and surgical procedures which require immediate results for critical decisions.

The introduction of new and advanced POC diagnostics such as Afinion HbA1c Dx test, a point of care diagnostic for the testing of diabetes by Abbott expected to drive the growth of the point of care testing market in developed as well as emerging countries, during the forecast period 2019-2026.

Market Segmentation

"Blood Glucose Monitoring to Account for the Highest Market Share by 2026"

Blood glucose monitoring is anticipated to account for the highest market share in the global point-of-care diagnostics market due to its status of diabetes as one of the most prevalent diseases. The new product launches for the blood glucose monitoring segment are driving the growth of the segment, and the same is expected to drive the growth of the market during the forecast period. Some of the other factors anticipated to drive the growth of the blood glucose monitoring segment are the constant requirement of regular testing for the treatment and management for the patients of diabetes and the increasing need for efficient testing in homecare settings.

To know how our report can help streamline your business, Speak to Analyst

The blood glucose monitoring segment accounted for a market share of 61.1% in 2018 and is expected to increase during the forecast period. In terms of considerations of ease of usage, blood glucose monitoring point-of-care (POC) diagnostics are preferred. These factors are also driving the growth of the blood glucose monitoring segment. The infectious diseases segment is estimated to grow at a faster CAGR during the forecast period. The infectious diseases segment is undergoing a growth due to the increase in the prevalence of infectious diseases. This is anticipated to fuel the growth of the segment during the forecast period.

Regional Analysis 

"Increasing Demand for Point-of-Care (POC) Testing for the Rapid and Accurate Diagnostic Outcomes Expected to Result in The Highest CAGR in the Asia Pacific"

North America generated a revenue of US$ 6,125.5 Mn in 2018 and is anticipated to account for a dominant share in the global POC testing market during the forecast period. Growth witnessed in the region is likely to be driven by the increasing demand for technologically advanced point-of-care (POC) diagnostics with increasing accuracy, which result in significantly in rapid point of care decisions. This is especially applicable in instances where there are critical medical cases where the individual requires immediate decisions for the treatment and management of serious disorders.

North America Point of Care (POC) Diagnostics Market Size, 2018

To get more information on the regional analysis of this market, Request a sample

In emerging countries such as India and China, the rise in awareness regarding point-of-care (POC) diagnostics and the increasing demand for accurate diagnostics is fueling growth in rapid diagnostics market during the forecast period. In countries like China and India, due to the development of the healthcare infrastructure and increasing healthcare expenditure, new products are being launched. In Japan, there is a significant demand for POC diagnostics due to the demand and availability of advanced point-of-care (POC) Diagnostics and the high proportion of the geriatric population.

 KeyMarket Drivers

"F. Hoffmann-La Roche Ltd, To Be the Leading Player in The Point of Care Diagnostics Market"

F. Hoffmann-La Roche Ltd, emerged as the leading player with the highest market share in 2018, as the company has several technologically advanced and specialized products as per varied indications in its family of point-of-care (POC) diagnostics. This range has several point-of-care (POC) diagnostics according to various settings such as the emergency rooms, homecare, doctor’s offices, and personal use. Also, other market players are also launching new products such as Abbott, which recently launched the product offering of Afinion HbA1c Dx test. Other players operating in the rapid diagnostics market are Abbott, Johnson & Johnson Services, Inc., Becton, Dickinson and Company (BD), Quidel Corporation, Sekisui Diagnostics, Danaher, Siemens Healthcare GmbH, AccuBioTech Co., Ltd., Chembio Diagnostic Systems, Inc., EKF Diagnostics Holdings plc, Instrumentation Laboratory (A Werfen Company), Nova Biomedical, and ​PTS Diagnostics.

List of Companies Profiled

  • Abbott

  • Johnson & Johnson Services, Inc.

  • Becton, Dickinson and Company (BD)

  • Quidel Corporation

  • Sekisui Diagnostics

  • Danaher

  • Siemens Healthcare GmbH

  • AccuBioTech Co., Ltd.

  • Chembio Diagnostic Systems, Inc.

  • EKF Diagnostics Holdings plc

  • Instrumentation Laboratory (A Werfen Company)

  • Nova Biomedical

  • PTS Diagnostics

Report Coverage

The increasing demand for rapid diagnostics in the general population is one of the key factors driving the growth of the global point of care testing market. The increasing R&D initiatives in the POC diagnostics market and the recent product launches are also positively contributing to the growth of the market. The report on global market focuses on size in terms of revenue (US$ Mn), of rapid diagnostics, for the period 2015-2026.

To gain extensive insights into the market, Request for Customization

The report offers information about various dynamics of the market, including drivers, restraints, opportunities for players in the point-of-care diagnostics market, and trends. The report analyzes and evaluates the current market size, growth rate, and forecast figure of the global market, with regards to the product, which is segmented into the blood glucose monitoring, infectious diseases, cardiometabolic diseases, pregnancy and fertility testing products, hematology testing products, and others. Based on the end-user, the market is categorized into hospital bedside, physician’s office lab, urgent care & retail clinics, and home and self-testing.

The report also offers key insights related to an overview of POC diagnostics market (2018) - for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, overview of the number of point-of-care (POC) diagnostics procedures by key countries, overview of price analysis of types of rapid tests, overview of regulatory scenario by key countries, overview of reimbursement scenario by key countries, pipeline analysis, new product launches and key industry developments - mergers, acquisitions, and partnerships and key growth indicators of POC diagnostics market.




By Product

  • Blood Glucose Monitoring

  • Infectious Diseases

  • Cardiometabolic Diseases

  • Pregnancy and Fertility Testing Products

  • Hematology Testing Products

  • Others

By End User

  • Hospitals Bedside

  • Physician’s Office Lab

  • Urgent Care & Retail Clinics

  • Home and Self Testing

By Geography

  • North America (U.S., and Canada)

  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and the Rest of Latin America)

  • Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Key Industry Developments

  • In June 2019, Abbott announced the launch of Afinion HbA1c Dx test, a point of care (POC) diagnostic for the testing of diabetes

  • In May 2016, Koninklijke Philips N.V. announced the launch of a new handheld blood test called the Minicare I-20 for the rapid point-of-care diagnosis of heart attack

Frequently Asked Questions

Fortune Business Insights says that the point-of-care (POC) diagnostics market is projected to reach USD 28,379.6 Million by 2026.

In 2018, the market was valued at USD 17,019.5 Million.

Growing at a CAGR of 6.6%, the market will exhibit faster growth in the forecast period (2019-2026).

Blood glucose monitoring products is expected to be leading in the market during the forecast period.

Increasing technological advancements in disease diagnosis is the key factor in driving the global point-of-care (POC) diagnostics market

Abbott and F. Hoffmann-La Roche Ltd are the top players in the point-of-care (POC) diagnostics market.

North America is expected to hold the highest market share in the market.

Rapid patient monitoring, over-the-counter testing, and cheaper diagnostic devices are the trends expected to increase the market value of point-of-care (POC) diagnostics.

Increased accessibility to self-diagnostics devices, faster & highly accurate diagnosis, and portable devices to drive the adoption of point-of-care (POC) diagnostics.

Point-of-Care Diagnostics Market Size, Share and Global Industry Trend Forecast till 2026
  • Aug, 2019
  • 2018
  • 2015-2017
  • 133


  • 4850

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.